Gauthier Marianne, Pitre-Champagnat Stéphanie, Tabarout Farid, Leguerney Ingrid, Polrot Mélanie, Lassau Nathalie
IR4M-UMR 8081, Institut Gustave Roussy, 94805 Villejuif cedex, France.
World J Radiol. 2012 Jul 28;4(7):291-301. doi: 10.4329/wjr.v4.i7.291.
To evaluate the sources of variation influencing the microvascularization parameters measured by dynamic contrast-enhanced ultrasonography (DCE-US).
Firstly, we evaluated, in vitro, the impact of the manual repositioning of the ultrasound probe and the variations in flow rates. Experiments were conducted using a custom-made phantom setup simulating a tumor and its associated arterial input. Secondly, we evaluated, in vivo, the impact of multiple contrast agent injections and of examination day, as well as the influence of the size of region of interest (ROI) associated with the arterial input function (AIF). Experiments were conducted on xenografted B16F10 female nude mice. For all of the experiments, an ultrasound scanner along with a linear transducer was used to perform pulse inversion imaging based on linear raw data throughout the experiments. Semi-quantitative and quantitative analyses were performed using two signal-processing methods.
In vitro, no microvascularization parameters, whether semi-quantitative or quantitative, were significantly correlated (P values from 0.059 to 0.860) with the repositioning of the probe. In addition, all semi-quantitative microvascularization parameters were correlated with the flow variation while only one quantitative parameter, the tumor blood flow, exhibited P value lower than 0.05 (P = 0.004). In vivo, multiple contrast agent injections had no significant impact (P values from 0.060 to 0.885) on microvascularization parameters. In addition, it was demonstrated that semi-quantitative microvascularization parameters were correlated with the tumor growth while among the quantitative parameters, only the tissue blood flow exhibited P value lower than 0.05 (P = 0.015). Based on these results, it was demonstrated that the ROI size of the AIF had significant influence on microvascularization parameters: in the context of larger arterial ROI (from 1.17 ± 0.6 mm(3) to 3.65 ± 0.3 mm(3)), tumor blood flow and tumor blood volume were correlated with the tumor growth, exhibiting P values lower than 0.001.
AIF selection is an essential aspect of the deconvolution process to validate the quantitative DCE-US method.
评估影响动态对比增强超声(DCE-US)测量微血管化参数的变异来源。
首先,我们在体外评估了超声探头手动重新定位和流速变化的影响。使用定制的模拟肿瘤及其相关动脉输入的体模装置进行实验。其次,我们在体内评估了多次注射造影剂和检查日的影响,以及与动脉输入函数(AIF)相关的感兴趣区域(ROI)大小的影响。在异种移植的B16F10雌性裸鼠上进行实验。对于所有实验,在整个实验过程中使用超声扫描仪和线性换能器基于线性原始数据进行脉冲反转成像。使用两种信号处理方法进行半定量和定量分析。
在体外,无论是半定量还是定量的微血管化参数,均与探头重新定位无显著相关性(P值范围为0.059至0.860)。此外,所有半定量微血管化参数均与血流变化相关,而只有一个定量参数,即肿瘤血流量,其P值低于0.05(P = 0.004)。在体内,多次注射造影剂对微血管化参数无显著影响(P值范围为0.060至0.885)。此外,已证明半定量微血管化参数与肿瘤生长相关,而在定量参数中,只有组织血流量的P值低于0.05(P = 0.015)。基于这些结果,已证明AIF的ROI大小对微血管化参数有显著影响:在较大动脉ROI(从1.17±0.6 mm³至3.65±0.3 mm³)的情况下,肿瘤血流量和肿瘤血容量与肿瘤生长相关,P值低于0.001。
AIF选择是验证定量DCE-US方法的反卷积过程的一个重要方面。